Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03245580 · ClinicalTrials.gov registry record · NA

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

A NA study of Liver Diseases, sponsored by Parkview Health.

Completed
Registry status
NA
Development phase
153
Enrollment target
7
Study locations

NCT03245580 is a NA study of Liver Diseases that has completed, run by Parkview Health. The registered enrollment target is 153 participants, below the 61,154-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03245580, a NA study of Liver Diseases, has completed, sponsored by Parkview Health.

COMPLETED
Registry status
NA
Development phase
153 participants
Enrollment target
7
Study locations

Study Summary

The primary purpose of this prospective, randomized, multicenter study is to evaluate and compare the amount and quality of tissue samples yielded in a liver biopsy comparing 2 different techniques of EUS guided CORE liver biopsy for benign disease. The two techniques: "modified Wet suction" and "Slow pull" technique of collecting tissue from a liver biopsy via Endoscopic Ultrasound (EUS).

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Core Liver Biopsy

Study Locations (7)

Indiana

  • Parkview Regional Medical Center - Fort Wayne
  • Indiana University - Indianapolis

Alabama

  • University South Alabama - Mobile

California

  • Santa CLara Valley Medical Center - San Jose

Louisiana

  • Oschner Health System - New Orleans

Pennsylvania

  • Geisinger Medical Center - Danville

Texas

  • Baylor Medical Center - Houston

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2018-03-08
Est. Completion 2020-09-15
Phase NA

Sponsor

Parkview Health

5 total trials

What the Registry Record Tells You About NCT03245580

The ClinicalTrials.gov registry entry for NCT03245580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,154-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Parkview Health, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Core Liver Biopsy is the first listed.

NCT03245580 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Indiana, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT03245580 about?

NCT03245580 is a clinical study titled "Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)". The primary purpose of this prospective, randomized, multicenter study is to evaluate and compare the amount and quality of tissue samples yielded in a liver biopsy comparing 2 different techniques of EUS guided CORE liver biopsy for benign disease. The two techniques: "modified Wet suction" and "Sl...

What is the current status of trial NCT03245580?

This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2018-03-08. Estimated completion is 2020-09-15.

What conditions does trial NCT03245580 study?

This clinical trial studies the following conditions: Liver Diseases.

What interventions are being tested in trial NCT03245580?

The interventions under investigation include: Core Liver Biopsy (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03245580?

This trial is sponsored by Parkview Health, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03245580 being conducted?

This trial has 7 study locations across Alabama, California, Indiana, Louisiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.